TITLE

Vaccine development strategies for improving immunization: the role of modern immunology

AUTHOR(S)
Levine, Myron M.; Sztein, Marcelo B.
PUB. DATE
May 2004
SOURCE
Nature Immunology;May2004, Vol. 5 Issue 5, p460
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
An ideal vaccine has certain biological and physical characteristics. Technological advances have provided new strategies that may help the design of such a vaccine.
ACCESSION #
13009186

 

Related Articles

  • Part II: Childhood vaccinations. Diggle, Linda // Practice Nurse;6/13/2003, Vol. 25 Issue 11, p67 

    Reports on the Learning to Support Practice series focusing on vaccination for children. Discussion on vaccination and immunization; Phases of vaccine development; Types of vaccines; Contraindications to vaccination.

  • Pathogenic epitopes, heterologous immunity and vaccine design. Welsh, Raymond M.; Fujinami, Robert S. // Nature Reviews Microbiology;Jul2007, Vol. 5 Issue 7, p555 

    Substantial research has been directed towards the development of a new generation of vaccines that are based on the inclusion of immunogenic epitopes in recombinant vectors. Here we examine the evidence that under certain conditions immunogenic epitopes can do more harm than good and might...

  • Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response. Kwissa, Marcin; Lindblad, Erik B.; Schirmbeck, Reinhold; Reimann, Joerg // Journal of Molecular Medicine;Aug2003, Vol. 81 Issue 8, p502 

    The study explores the possibility of efficiently codelivering DNA vaccines and protein-based vaccines by formulation with aluminum phosphate (AlPO4). When mixed with aluminum adjuvants, plasmid DNA bound tightly onto aluminum hydroxide [Al(OH)3] but not to AlPO4. Different doses of DNA vaccines...

  • Learning from our successes. Dadley-Moore, Davina // Nature Reviews Immunology;Apr2006, Vol. 6 Issue 4, p1 

    Presents information on research being done by Troy Querec and colleagues on the reason for the effectiveness of yellow-fever vaccine, published in "The Journal of Experimental Medicine." Main component of yellow-fever vaccine; Description on how yellow-fever vaccine works; Details on the...

  • In the mood for wiping out vaccine-preventable diseases. Fleck, Fiona // Bulletin of the World Health Organization;Apr2014, Vol. 92 Issue 4, p236 

    An interview with executive vice president of the Sabin Vaccine Institute, Ciro de Quadros, is presented. He discusses how he became interested in immunization while involved with a smallpox programme in Brazil in 1969, what disease surveillance and containment is and how he helped to develop...

  • Immune mechanisms of protection: can adjuvants rise to the challenge? McKee, Amy S.; MacLeod, Megan K. L.; Kappler, John W.; Marrack, Philippa // BMC Biology;2010, Vol. 8, p37 

    For many diseases vaccines are lacking or only partly effective. Research on protective immunity and adjuvants that generate vigorous immune responses may help generate effective vaccines against such pathogens.

  • Recommended Adult Immunization Schedule -- United States, October 2005--September 2006.  // MMWR: Morbidity & Mortality Weekly Report;10/14/2005, Vol. 54 Issue 40, pQ-1 

    Focuses on the recommended Adult Immunization Schedule in the U.S. for October 2005 to September 2006. Difference of the 2005-2006 schedule from the previous schedule; Recommended dose of tetanus diphtheria vaccine for people aged 50-64 years; Web sites to access for further information on...

  • Do Vaccines Save Lives? Yes They Do! LERNOUT, Tinne; THEETEN, Heidi; LEURIDAN, Elke; VAN DAMME, Pierre // Acta Medica Portuguesa;mar/abr2014, Vol. 27 Issue 2, p160 

    Since their introduction and widespread use, vaccines have been very successful in reducing morbidity and mortality of the diseases they target, at an individual level and through herd immunity. The impact on the mortality has been rapid and easy to measure for some diseases, such as diphtheria,...

  • Antigen fusion with C3d3 augments or inhibits humoral immunity to AAV genetic vaccines in a transgene-dependent manner. Logan, Grant J.; Wang, Lina; Maolin Zheng; Coppel, Ross L.; Alexander, Ian E. // Immunology & Cell Biology;Feb2010, Vol. 88 Issue 2, p228 

    Genetic fusion of tandem repeats of the complement molecule C3d has been shown to considerably enhance immune responses to genetic vaccines. We have investigated the applicability of this approach to augment humoral immune responses toward vaccines delivered by recombinant adeno-associated virus...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics